{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

hw4_771

# hw4_771 - Stat 771 Homework 4 due Monday April 18 We will...

This preview shows pages 1–2. Sign up to view the full content.

Stat 771 Homework 4, due Monday, April 18 We will consider data from an AIDS trial comparing two drugs, ddI and ddC (Abrams et al., 1995). This was a multicenter, randomized, open label trial to compare ddI to ddC in HIV-infected patients who were intolerant to or had failed ZDV therapy. Participants were men and women, aged 15–67, who had either advanced to AIDS or had a CD4 lymphocyte count 300 (this is low). The primary objective is to find out which therapy is better, ddI or ddC, at increasing lymphocyte counts; CD4 T-cell counts are widely-used biomarkers measuring the progression of HIV infection and AIDS (low cells counts are the hallmark of AIDS). There are m = 467 patients that could potentially be observed at 5 time points: 0, 2, 6, 12, and 18 months after therapy started. At 0 months, no there are no differences in the populations, and we will include the CD4 count at 0 months as a base line measurement in the model statement. Instead of working with the CD4 counts directly, we will take the square root and work with Y ij = p CD 4 ij . The square root is a common variance stabilizing transformation for counts, often used with Poisson data. This is a fairly large, messy data set with missing observations, and observations taken at unequally spaced times. The overarching goal is to find out whether there is a treatment effect ( randgrp g i = 1 for ddI g i

This preview has intentionally blurred sections. Sign up to view the full version.

View Full Document
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}

### Page1 / 2

hw4_771 - Stat 771 Homework 4 due Monday April 18 We will...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document
Ask a homework question - tutors are online